Vaccines

17 Oct 2011 Dendreon Begins Enrollment in Phase 2 Neu-ACT Trial for Second Active Cellular Immunotherapy Product Candidate, DN24-02
13 Oct 2011 Sinovac Selected by Beijing CDC to Supply Seasonal Influenza Vaccine Anflu(R) to Beijing Citizens
13 Oct 2011 Innavirvax Announces Phase I/IIa Clinical Trial Authorization Granted by AFSSAPS for its VAC-3S Vaccine for the Treatment of HIV Infections
12 Oct 2011 The Michael J. Fox Foundation Awards AFFiRiS $1.5 Million for the Clinical Development of the First Parkinson's Disease Vaccine
12 Oct 2011 Medicago Successfully Completes First Stage of Collaboration Agreement with Top 10 Global Pharmaceutical Company for the Development of a Non-influenza VLP Vaccine Candidate
11 Oct 2011 Advaxis Granted Pre-IND Meeting with FDA for ADXS-HER2, an Immunotherapy for HER2 Expressing Cancers
11 Oct 2011 Aduro BioTech Announces First Patient Treated in Phase 2 Pancreatic Cancer Trial
11 Oct 2011 Pevion's Therapeutic Candida Vaccine Shows Robust Systemic and Mucosal Immunogenicity, While Epidemiological Survey Confirms Excellent Market Potential
10 Oct 2011 Inovio Pharmaceuticals and VGX International to Advance Therapeutic Hepatitis C and Hepatitis B Synthetic Vaccines into Clinical Studies
10 Oct 2011 Dynavax Reports Positive Immunogenicity Data From an Analysis of Hypo-Responsive Populations in HEPLISAV(TM) Phase 3 Trial
07 Oct 2011 Dynavax Reports Diabetic Subset Data From Modified Intent to Treat Analysis of the HEPLISAV(TM) Phase 3 Trial in Healthy Adults Over Age 40
05 Oct 2011 Inovio Pharmaceuticals' Synthetic Vaccine for Cancer Recognized as Most Promising Research at Global Vaccine Congress
04 Oct 2011 Mymetics Reclaims Innovative Intra-Nasal Influenza Vaccine
04 Oct 2011 Ono to Enter into License Agreements with Merck KGaA
03 Oct 2011 GeoVax Phase 2a Clinical Trial Completes Enrollment
03 Oct 2011 NOVAVAX Reports Positive Results From Phase I Trial of Respiratory Syncytial Virus Vaccine Candidate
03 Oct 2011 Vical Reports Prophylactic and Therapeutic Efficacy With Herpes Simplex Vaccines in Guinea Pig Model
03 Oct 2011 Dynavax Reports Modified Intent to Treat Analysis From the HEPLISAV(TM) Phase 3 Trial in Healthy Adults Over Age 40
28 Sep 2011 Aptiv Solutions Awarded Pivotal International Cancer Vaccine Trial
27 Sep 2011 Circassia's Hay Fever Treatment Improves Patients' Allergy Symptoms in Phase II Clinical Trial
26 Sep 2011 Clinical Data Published in Vaccine Demonstrate Robust Immune Response With Agenus' Herpes Vaccine Containing QS-21 Adjuvant
26 Sep 2011 Regulatory Update: GlaxoSmithKline receives Complete Response letter from FDA for candidate meningococcal and Hib combination vaccine
22 Sep 2011 Allovectin(R) Demonstrates Synergistic Efficacy With Anti-CTLA-4 Antibody in Melanoma Animal Model
21 Sep 2011 RXi Pharmaceuticals Licenses Novel, Targeted Cancer Vaccine for Gynecological Cancers
21 Sep 2011 Sanofi Pasteur Acquires Exclusive, Worldwide License for Acne Vaccine and Treatment

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top